Disease-Modifying Treatment in Progressive Multiple Sclerosis

被引：0
作者：
John Robert Ciotti
Anne Haney Cross
机构：
[1] Washington University in St. Louis,
来源：
Current Treatment Options in Neurology | 2018年 / 20卷
关键词：
Progressive multiple sclerosis; Disease-modifying therapy; Neuroprotection; Remyelination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies
    Simone, Isabella Laura
    Tortorella, Carla
    Ghirelli, Alma
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [22] Evaluating response to disease-modifying therapy in relapsing multiple sclerosis
    Freedman, Mark S.
    Abdoli, Mohammad
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (04) : 407 - 423
  • [23] Disease-modifying therapies in multiple sclerosis: A focused review of rituximab
    Alping, Peter
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (05) : 550 - 564
  • [24] Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies
    McGinley, Marisa P.
    Cola, Philip A.
    Fox, Robert J.
    Cohen, Jeffrey A.
    Corboy, John J.
    Miller, Deborah
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (12) : 1581 - 1589
  • [25] Infections in patients with multiple sclerosis: Implications for disease-modifying therapy
    Celius, E. G.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 : 34 - 36
  • [26] Disease-modifying therapies in relapsing-remitting multiple sclerosis
    Gonzalez-Andrade, Fabricio
    Luis Alcaraz-Alvarez, Jose
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 365 - 373
  • [27] The emergence of follow-on disease-modifying therapies for multiple sclerosis
    Moss, Brandon P.
    Cohen, Jeffrey A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (12) : 1560 - 1565
  • [28] Fostering adherence to injectable disease-modifying therapies in multiple sclerosis
    Lugaresi, Alessandra
    Rottoli, Maria Rosa
    Patti, Francesco
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (09) : 1029 - 1042
  • [29] Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies
    Talente, Bari
    Finseth, Lisbet
    Blake, Natalie
    Costello, Kathleen
    Schmidt, Hollie
    Vandigo, Joe
    Oehrlein, Elisabeth M.
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2025, 17 : 199 - 215
  • [30] Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?
    Lonergan, Roisin
    Kinsella, Katie
    Duggan, Marguerite
    Jordan, Sinead
    Hutchinson, Michael
    Tubridy, Niall
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (12): : 1528 - 1531
12345